Biohit Oyj - Annual Financial Report

BIOHIT'S FINANCIAL STATEMENTS AND REPORT OF BOARD OF DIRECTORS FOR 2009 PUBLISHED

BIOHIT OYJ STOCK EXCHANGE RELEASE ON 31 MARCH 2010 AT 6:45 PM                  

BIOHIT'S FINANCIAL STATEMENTS AND REPORT OF BOARD OF DIRECTORS FOR 2009 HAVE    
BEEN PUBLISHED                                                                  

The financial statements, the report of the Board of Directors, including the   
Corporate Governance statement, and the auditor's report of Biohit Oyj for the  
financial year 2009 have been published today in Finnish and English on Biohit's
web site at www.biohit.com/investors, and as attachment to this release.        

The Annual Report 2009, which also includes the above mentioned documents, as   
well as the annual summary will be published in Finnish and English on Biohit's 
web site during week 16 the latest.                                             

Hardcopies of the Annual Report may be ordered from Biohit, via telephone:      
+358-9-7738 61, via email comms@biohit.com or via the order form at Biohit's    
website.                                                                        

ANNUAL SUMMARY OF STOCK EXCHANGE RELEASES                                       

An annual summary of Biohit Oyj's stock exchange releases and announcements     
published in 2009 is available at www.biohit.com/exreleases. Additionally, the  
summary is published in the Annual Report. The website also includes all other  
stock exchange releases and announcements published by Biohit since 1999.       

Some of the information included in the releases might be out of date.          

Jussi Heiniö                                                                    
VP, Administration and Legal Affairs                                            
Biohit Oyj                                                                      


Further information:                                                            
Jussi Heiniö                                                                    
VP, Administration and Legal Affairs                                            
Tel: +358-9-7738 6223                                                          
Email: jussi.heinio@biohit.com                                                  

Distribution:                                                                   
NASDAQ OMX Helsinki Oy                                                          
Central storage facility (www.oam.fi)                                           
Press                                                                           
www.biohit.com                                                                  


About Biohit Oyj                                                                

Established in 1988, Biohit Oyj is a Finnish biotechnology company, acting on
the global market. Biohit's operations are based on a goal-oriented and
long-term innovation and patenting strategy. 
Biohit works with scientific communities to produce new technologies, products
and services based on research results and innovations that can be used to
develop safe and cost-effective liquid handling solutions for laboratory work
as well as diagnostic tests for the early detection and prevention of diseases
of the gastrointestinal tract. 

Biohit has two business segments: liquid handling and diagnostics. Liquid
handling products include electronic and mechanical pipettes, disposable tips
as well as pipette maintenance and calibration services for research
institutions, healthcare and industrial laboratories. 

The diagnostics business comprises products and analysis systems for the early
diagnosis of gastrointestinal diseases, such as the blood-sample based
GastroPanel examinations for the diagnosis of stomach illnesses and associated
risks, quick tests for the diagnosis of lactose intolerance and H. pylori
infection in connection with gastroscopy, and the ColonView examination for the
early detection of intestinal bleeding that indicates a risk of colorectal
cancer. The Acetium innovation reduces carcinogenic acetaldehyde in anacidic
stomachs. 

The Biohit Group employs around 370 people. The company is headquartered in
Helsinki, Finland, and has subsidiaries in France, Germany, the UK, Russia,
India, China, Japan and the USA, as well as a representative office in
Singapore. Additionally, Biohit's products are sold by approximately 450
distributors in 70 countries. 

Biohit's series B share (BIOBV) is quoted on NASDAQ OMX Helsinki, Small
cap/Healthcare since 1999. 

Read more at www.biohit.com

Attachments:

biohit_financialstatements-2009_eng.pdf